Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning

Abstract

Our findings provide an improved understanding of the ARV market that can help countries strengthen policy measures to increase their bargaining power in price negotiations and the use of TRIPS flexibilities, with a special emphasis on negotiations with generic manufacturers.